The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy

10.1038/s41586-024-08276-1

Affiliations
Laura Bornes, Lennart J van Winden, Veerle C M Geurts, Beaunelle de Bruijn, Leyla Azarang, Mirthe Lanfermeijer, Marika Caruso, Natalie Proost, Manon Boeije, Jeroen O Lohuis, Guillaume Belthier, Eulàlia Noguera Delgado, Nadia de Gruil, Judith R Kroep, Marieke van de Ven, Renee Menezes, Jelle Wesseling, Marleen Kok, Sabine Linn, Annegien Broeks, Huub H van Rossum, Colinda L G J Scheele, Jacco van Rheenen

DOI: 10.1038/s41586-024-08276-1

Abstract
The response of breast cancer to neoadjuvant chemotherapy (NAC) varies substantially, even when tumours belong to the same molecular or histological subtype

Keywords
NAC，CD45，tumor

関連製品

カタログ番号	製品名	説明	ターゲット
HY195127	CD45		T200, Leukocyte common antigen, CD45, L-CA, Receptor-type tyrosine-protein phosphatase C, PTPRC

組換えタンパク質

抗体

アッセイキット

The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy

クイックアクセス

お問い合わせ